BCWorld Pharm
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Bcworldpharm makes prescription medicines, drugs used to treat, prevent, and manage a range of diseases, and supplies them to domestic pharmaceutical companies as well as exporting to markets across Europe, Latin America, the Middle East, CIS countries, and Asia.
Listed on KOSDAQ, Korea's small-cap and technology board, it serves both end-market customers and other drug makers that outsource manufacturing. Beyond its own branded products, the company operates contract manufacturing (CMO) and contract development-and-manufacturing (CDMO) businesses, and is also pursuing overseas licensing of its in-house research and development technology.
Summary is AI-generated and may contain errors · figures from DART filings
Bcworldpharm consolidates two subsidiaries, BCWorld Healthcare, a prescription-drug maker, and Heart Ad, an advertising agency, into its group financial statements.
BCWorld Pharm in five facts
What does BCWorld Pharm do?
Bcworldpharm makes prescription medicines, drugs used to treat, prevent, and manage a range of diseases, and supplies them to domestic pharmaceutical companies as well as exporting to markets across Europe, Latin America, the Middle East, CIS countries, and Asia.
Where is BCWorld Pharm listed and in which sector?
BCWorld Pharm (Korean name: 비씨월드제약) trades under KRX code 200780 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Pharmaceuticals.
How large is BCWorld Pharm?
Its market capitalisation was US$23.5M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were BCWorld Pharm's latest annual revenue and operating profit?
For fiscal year 2025, BCWorld Pharm reported revenue of US$57.2M, operating profit of US$1.5M and a net loss of US$2.4M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 1.3% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.